Advertisement
UK markets close in 4 hours 59 minutes

  • FTSE 100

    8,107.58
    +28.72 (+0.36%)
     

  • FTSE 250

    19,820.91
    +218.93 (+1.12%)
     

  • AIM

    755.83
    +2.71 (+0.36%)
     

  • GBP/EUR

    1.1659
    +0.0002 (+0.02%)
     

  • GBP/USD

    1.2511
    +0.0000 (+0.00%)
     

  • Bitcoin GBP

    51,409.58
    +697.15 (+1.37%)
     

  • CMC Crypto 200

    1,390.96
    -5.57 (-0.40%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    83.91
    +0.34 (+0.41%)
     

  • GOLD FUTURES

    2,359.70
    +17.20 (+0.73%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,045.42
    +128.14 (+0.72%)
     

  • CAC 40

    8,037.38
    +20.73 (+0.26%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

BAT nicotine inhaler licensed as medicinal product in UK

Reuters - UK Focus

LONDON, Sept 12 (Reuters) - A new nicotine inhaler to be sold by a unit of British American Tobacco (LSE: BATS.L - news) has been licensed in the UK as a medicinal product, marking the arrival of a new competitor in the fast-growing electronic cigarette market.

The Voke Inhaler contains no electronics, heat or combustion and is designed to rival both e-cigarettes and nicotine-replacement therapies, such as gum and patches.

The product was developed by Kind Consumer, working with Consort Medical (Other OTC: CSRMY - news) , and the next step will be to submit a variation to the licence granted by the Medicines and Healthcare products Regulatory Agency (MHRA) to support full-scale commercialisation by BAT's Nicoventures, the companies said.

(Reporting by Ben Hirschler, Editing by Paul Sandle)